AAO, PAAO joint meeting offers professional resources
October 1st 2002There's nothing else like it in the world. The joint meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology is the best opportunity for you to meet your colleagues from around the globe and exchange information and skills for the advancement of the profession.
A hope that ophthalmologists'will be wise' with priorities
October 1st 2002In January 2001, I was a guest lecturer at the Cuban Ophthalmological Society meeting. I was amazed to see how eager the surgeons were to learn anything that would help them take better care of their patients. In Cuba, ophthalmologists are paid $25 per month. It is true that all Cubans get a housing and food stipend in addition to their base salary, but the amount is meager compared with U.S. standards.
Commitment to R&D strengthens Allergan product pipeline
October 1st 2002Irvine, CA-When Allergan announced in January that it planned to spin off its optical medical device business into a separate company called Advanced Medical Optics (AMO), David E.I. Pyott, chairman, president, and CEO of Allergan, said the company would evolve into a specialty pharmaceutical company.
Two-piece anterior chamber IOL offers hope for myopia
October 1st 2002New York-An anterior chamber phakic IOL for the treatment of high myopia combats the four major problems facing anterior chamber lenses, according to cataract sur-geon Charles D. Kelman, MD, who described the advantages of his invention.
Phakic toric IOL corrects total refractive error
October 1st 2002Mainz, Germany-A phakic toric IOL is beneficial in correcting myopia and hyperopia as well as regular astigmatism in the range of 2 to 7 D, according to H. Burkhard Dick, MD, one of the investigators who reported on the multicenter clinical trial of the lens.
Developing neuroprotective drugs for glaucoma no easy task
October 1st 2002Neuroprotection is a concept that originated in the CNS community with the development of therapies aimed at preventing or retarding the manifestations of disorders such as Parkinson's and Alzheimer's diseases, stroke, and head trauma. Less than 15 years ago, the ophthalmic community began to discuss this concept as a novel way to preserve vision in disorders of the retina.
Laser, PDT, surgery, corticosteroids can treat POHS
October 1st 2002Presumed ocular histoplasmosis syndrome (POHS) is characterized by a classic triad of discrete atrophic choroidal scars in the macula or midperiphery, known as "histo spots"; peripapillary atrophy; and choroidal neovascularization (CNV). It occurs bilaterally in about 60% of patients.
Glare, halos less of a problem with larger treatment zone
October 1st 2002Minneapolis-A recent study indicates that extending the optical and treatment zones may result in fewer complaints about glare and halos from patients who undergo LASIK with the VISX Star S3 laser, according to Richard Lindstrom, MD, clinical professor of ophthalmology, University of Minnesota, Minneapolis.
PhotoPoint review: Further results found in AMD drug trial Santa Barbara, CA-Miravant Medic
October 1st 2002Santa Barbara, CA-Miravant Medical Technologies says 65.6% of patients who were treated three times over 2 years at a lower dose of its PhotoPoint SnET2 photodynamic therapy for wet age-related macular degeneration (AMD) maintained stable vision compared with 39.3% of patients taking placebo.
Cataract trial weighs same-day discharge, next-day review
September 15th 2002Fort Lauderdale, FL-Patients undergoing elective phacoemulsification can be discharged the same day and return for follow-up 2 weeks later, achieving the same results as those also seen 1 day postop, according to Christopher Tinley, MB, ChB, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Estrogen exposure may protect women against cataract
September 15th 2002Fort Lauderdale, FL-Estrogen-whether endogenous or from hormone replacement therapy (HRT)-appears to help prevent cataract formation, according to Australian researcher Christine Younan, MD, who reported her findings at the annual meeting of the Association for Research in Vision and Ophthalmology.
Analyze your service lines from a financial perspective
September 15th 2002Dorado, Puerto Rico-Cataract and other major surgeries made up a large part of ophthalmologists' practice revenue in 1995. Clinical services also contributed substantially to the bottom line. But over the last 7 years, surgeons have seen a decline in both these areas, noted practice management consultant James Rienzo.
Awareness of PRK, LASEK benefits swings pendulum back
September 15th 2002Ottawa-Thanks to advances in techniques and technology, surface ablation with PRK or LASEK for eyes with low-to-moderate refractive errors yields visual outcomes equivalent to LASIK with lower risks of vision-threatening complications and fewer re-treatments, said W. Bruce Jackson, MD.
Retinal endovascular surgery helps those with CRVO, HRVO
September 15th 2002Fort Lauderdale, FL-Vitrectomy with retinal vein cannulation and infusion of tissue plasminogen activator (t-PA) is a relatively safe procedure that improves vision in patients with central retinal vein occlusion (CRVO) or hemispheric retinal vein occlusion (HRVO), according to Jeffrey N. Weiss, MD.
High-speed OCT may be useful in diagnosing retinal diseases
September 15th 2002Fort Lauderdale, FL-A newly developed high-speed optical coherence tomography (OCT) system for recording 3-D images of the human retina promises to be a valuable tool for the diagnosis of retinal diseases, said Christoph K. Hitzenberger, PhD, associate professor of medical physics at the Institute of Medical Physics, University of Vienna, Austria.
Treating irregular astigmatism and keratoconus a challenge
September 15th 2002Irregular astigmatism, one of the most frequent complications of corneal refractive surgery, was relatively unnoticed and underestimated until video keratography showed that some irregular astigmatism is present in as high as 40% of patients who have undergone corneal refractive surgery.1
PRK may lead to apical scarring in hyperopic population
September 15th 2002Vancouver, British Columbia-Surgeons treating patients with high degrees of hyperopia should consider performing a procedure other than PRK because of the development of apical scarring with potential subsequent severe vision loss, according to Simon P. Holland, MD, clinical associate professor, department of ophthalmology, University of British Columbia, Vancouver.
Glaucoma patients experience hyperemia with medications
September 15th 2002Two glaucoma drugs approved last year, travoprost (Travatan, Alcon) and bimatoprost (Lumigan, Allergan), are associated with higher rates of hyperemia than the more established drug latanoprost (Xalatan, Pharmacia). However, the hyperemia is seldom a clinically significant side effect, according to a sampling of physicians who are familiar with all three drugs.
Exchange program opens eyes for a developing nation
September 15th 2002He journeyed to the United States and achieved the American dream-professional and personal success. Born in India, educated there and in Britain and the United States as an ophthalmologist, V.K. Raju, MD, settled in Morgantown, WV, and began his career as a professor in the department of ophthalmology at West Virginia University, and on the staff of Monongalia General Hospital.